Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Imiquimod for Cervical Intraepithelial Neoplasia Grade 2/3
2008-007763-16Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2009
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imiquimod in cervical intraepithelial neoplasia (CIN), sponsored by Medical University of Vienna. Primary endpoint: Efficacy of topical imiquimod in CIN 2/3. Started Jan 2009; status: completed.
02
Drugs
imiquimod
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on 2008-007763-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007763-16.